Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck: Current Investors Should Hold This Pharma Long-Term
Merck: Current Investors Should Hold This Pharma Long-Term
Merck: Current Investors Should Hold This Pharma Long-Term
Submitted by
admin
on October 30, 2012 - 11:33am
Source:
Seeking Alpha
News Tags:
Merck
Eli Lilly
Pfizer
Headline:
Merck: Current Investors Should Hold This Pharma Long-Term
Do Not Allow Advertisers to Use My Personal information
